Evaluation and feasibility study of telemedicine-based self-sampling for SARS-CoV-2

Not Applicable

• Conditions: COVID-19; U07.1; COVID-19, virus identified

• Registration Number: DRKS00027093
• Lead Sponsor: etzwerk Universitätsmedizin Klinikum rechts der Isar der TU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-10-31
• Study Start: 2021-12-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Indication for SARS-CoV-2 testing as per local recommendation
- Access for using an Android or iOS-Smartphone that is compatible with the Study software application
- Age =18 years
- Informed consent

Exclusion Criteria

- Current active, laboratory confirmed SARS-CoV-2 infection
- Mental deficiency or any other condition that results in lacking understanding of the provided study information

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of a completely telemedicine-based SARS-CoV-2 testing